Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Dai, W., Zhang, B., Jiang, X.M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., Liu, X., Xiao, G., Jiang, H., Rao, Z., Zhang, L.K., Xu, Y., Yang, H., Liu, H.(2020) Science 368: 1331-1335
- PubMed: 32321856 
- DOI: https://doi.org/10.1126/science.abb4489
- Primary Citation of Related Structures:  
6LZE, 6M0K - PubMed Abstract: 
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of SARS-CoV-2, M pro , is a key enzyme that plays a pivotal role in mediating viral replication and transcription ...